AU2003303029A1 - Tiotropium containing hfc solution formulations - Google Patents
Tiotropium containing hfc solution formulations Download PDFInfo
- Publication number
- AU2003303029A1 AU2003303029A1 AU2003303029A AU2003303029A AU2003303029A1 AU 2003303029 A1 AU2003303029 A1 AU 2003303029A1 AU 2003303029 A AU2003303029 A AU 2003303029A AU 2003303029 A AU2003303029 A AU 2003303029A AU 2003303029 A1 AU2003303029 A1 AU 2003303029A1
- Authority
- AU
- Australia
- Prior art keywords
- acid
- hfc
- solution formulation
- formulation according
- aerosol solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02028238 | 2002-12-16 | ||
EP02028238.0 | 2002-12-16 | ||
PCT/EP2003/013692 WO2004054580A1 (fr) | 2002-12-16 | 2003-12-04 | Formulations de solutions aux hfc contenant du tiotropium |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003303029A1 true AU2003303029A1 (en) | 2004-07-09 |
Family
ID=32524008
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003303029A Abandoned AU2003303029A1 (en) | 2002-12-16 | 2003-12-04 | Tiotropium containing hfc solution formulations |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1575588A1 (fr) |
JP (1) | JP2006510680A (fr) |
KR (1) | KR20050085650A (fr) |
CN (1) | CN1726038A (fr) |
AU (1) | AU2003303029A1 (fr) |
BR (1) | BR0317340A (fr) |
CA (1) | CA2510043A1 (fr) |
IL (1) | IL169178A0 (fr) |
MX (1) | MXPA05006383A (fr) |
PL (1) | PL375868A1 (fr) |
RU (1) | RU2005122444A (fr) |
WO (1) | WO2004054580A1 (fr) |
ZA (1) | ZA200503546B (fr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7273603B2 (en) * | 2003-07-11 | 2007-09-25 | Boehringer Ingelheim International Gmbh | HFC solution formulations containing an anticholinergic |
CN101203513A (zh) * | 2005-05-02 | 2008-06-18 | 贝林格尔·英格海姆国际有限公司 | 噻托溴铵的晶型 |
ES2393794T3 (es) * | 2005-05-02 | 2012-12-28 | Boehringer Ingelheim International Gmbh | Nuevas formas cristalinas de bromuro de tiotropio |
US9108962B2 (en) | 2005-12-19 | 2015-08-18 | Sicor, Inc. | Forms of tiotropium bromide and processes for preparation thereof |
US8163913B2 (en) * | 2005-12-19 | 2012-04-24 | Sicor Inc. | Forms of tiotropium bromide and processes for preparation thereof |
EP2201934A1 (fr) | 2008-12-23 | 2010-06-30 | CHIESI FARMACEUTICI S.p.A. | Produits de formule d'aérosol de tiotropium avec stabilité chimique améliorée |
SG181870A1 (en) | 2009-12-23 | 2012-07-30 | Chiesi Farma Spa | Aerosol formulation for copd |
EP2515855B3 (fr) | 2009-12-23 | 2023-05-03 | Chiesi Farmaceutici S.p.A. | Polythérapie pour la COPD |
GB201200525D0 (en) * | 2011-12-19 | 2012-02-29 | Teva Branded Pharmaceutical Prod R & D Inc | An inhalable medicament |
GB201200504D0 (en) * | 2011-12-19 | 2012-02-22 | Teva Branded Pharmaceutical Prod R & D Inc | An inhaler |
WO2013127738A1 (fr) | 2012-02-28 | 2013-09-06 | Boehringer Ingelheim International Gmbh | Nouvelle formulation de tiotropium contenant un gaz propulseur |
CA2885767A1 (fr) * | 2012-10-23 | 2014-05-01 | Cipla Limited | Composition pharmaceutique |
US20160250197A1 (en) * | 2013-11-22 | 2016-09-01 | Teva Branded Pharmaceutical Products R&D, Inc. | An inhalable medicament |
US10034866B2 (en) | 2014-06-19 | 2018-07-31 | Teva Branded Pharmaceutical Products R&D, Inc. | Inhalable medicament comprising tiotropium |
ES2904823T3 (es) * | 2016-09-19 | 2022-04-06 | Mexichem Fluor Sa De Cv | Composición farmacéutica que comprende bromuro de tiotropio |
ES2841649T5 (es) * | 2016-09-19 | 2024-04-24 | Mexichem Fluor Sa De Cv | Composición farmacéutica |
CA3037080C (fr) | 2016-09-19 | 2021-05-18 | Mexichem Fluor S.A. De C.V. | Compositions pharmaceutiques stables comprenant de l'indacaterol et du 1,1-difluoroethane (hfa 152a) pour utilisation dans des aerosols-doseurs |
BR112019005168A2 (pt) | 2016-09-19 | 2019-06-11 | Mexichem Fluor Sa De Cv | composição farmacêutica, recipiente vedado, inalador de dose medida, e, métodos para tratar um paciente que sofre ou susceptível de sofrer de um distúrbio respiratório, para melhoria da estabilidade de uma composição farmacêutica e do desempenho de aerossolização de uma composição farmacêutica e para reduzir o potencial de aquecimento global de uma composição farmacêutica |
EP3515432B1 (fr) | 2016-09-19 | 2021-08-25 | Mexichem Fluor S.A. de C.V. | Composition pharmaceutique comprenant glycopyrrolate |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100312357B1 (ko) * | 1992-12-09 | 2002-04-24 | 데이비드 이. 프랭크하우저 | 안정화된약제의에어로졸용액제제 |
DE10056104A1 (de) * | 2000-11-13 | 2002-05-23 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols |
-
2003
- 2003-12-04 CA CA002510043A patent/CA2510043A1/fr not_active Abandoned
- 2003-12-04 CN CNA2003801063667A patent/CN1726038A/zh active Pending
- 2003-12-04 JP JP2004559752A patent/JP2006510680A/ja active Pending
- 2003-12-04 KR KR1020057010885A patent/KR20050085650A/ko not_active Application Discontinuation
- 2003-12-04 BR BR0317340-2A patent/BR0317340A/pt not_active Expired - Fee Related
- 2003-12-04 RU RU2005122444/15A patent/RU2005122444A/ru not_active Application Discontinuation
- 2003-12-04 MX MXPA05006383A patent/MXPA05006383A/es not_active Application Discontinuation
- 2003-12-04 EP EP03813106A patent/EP1575588A1/fr not_active Withdrawn
- 2003-12-04 WO PCT/EP2003/013692 patent/WO2004054580A1/fr active Application Filing
- 2003-12-04 PL PL03375868A patent/PL375868A1/xx unknown
- 2003-12-04 AU AU2003303029A patent/AU2003303029A1/en not_active Abandoned
-
2005
- 2005-05-04 ZA ZA200503546A patent/ZA200503546B/xx unknown
- 2005-06-15 IL IL169178A patent/IL169178A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1726038A (zh) | 2006-01-25 |
WO2004054580A1 (fr) | 2004-07-01 |
PL375868A1 (en) | 2005-12-12 |
RU2005122444A (ru) | 2007-01-27 |
KR20050085650A (ko) | 2005-08-29 |
CA2510043A1 (fr) | 2004-07-01 |
ZA200503546B (en) | 2006-10-25 |
BR0317340A (pt) | 2005-11-08 |
JP2006510680A (ja) | 2006-03-30 |
EP1575588A1 (fr) | 2005-09-21 |
MXPA05006383A (es) | 2005-08-29 |
IL169178A0 (en) | 2007-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20090175802A1 (en) | Tiotropium containing hfc solution formulations | |
CA2531847C (fr) | Preparations de hfc en solution contenant un anticholinergique | |
AU2003303029A1 (en) | Tiotropium containing hfc solution formulations | |
EP0673240B1 (fr) | Formulations de solutions medicinales aerosol stabilisees | |
KR100600423B1 (ko) | 2개 이상의 활성 물질을 포함하는 연무질 약제학적 제형 | |
NZ236973A (en) | Propellant gas mixtures comprising at least two components one of which is partly fluorinated c 2-4 alkane, use in pharmaceutical preparations | |
US7736627B2 (en) | HFA suspension formulations containing an anticholinergic | |
KR20110096538A (ko) | 약제학적 에어로졸 조성물 | |
UA82413C2 (uk) | Спосіб одержання солей тіотропію, солі тіотропію, а також лікарський засіб, який їх містить | |
CA2479640C (fr) | Formulations de hfa en suspensions contenant un anticholinergique | |
JP5147158B2 (ja) | 無水物のhfa懸濁製剤 | |
US20030185766A1 (en) | HFA suspension formulations of an anhydrate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |